Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group study.
暂无分享,去创建一个
[1] M. L. Rosa. Glaucoma crónico de ángulo abierto , 2005 .
[2] R. Stodtmeister,et al. Autoregulation of ocular blood flow during changes in intraocular pressure , 1985, Graefe's Archive for Clinical and Experimental Ophthalmology.
[3] Y. Bilgili,et al. Short‐term effect of latanoprost on ocular circulation in ocular hypertension , 2004, Clinical & experimental ophthalmology.
[4] G. Richard,et al. Okuläre Hämodynamik beim Normaldruckglaukom: Effekte von Bimatoprost , 2004 .
[5] L. Verma,et al. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. , 2004, American journal of ophthalmology.
[6] G. Richard,et al. [Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost]. , 2004, Klinische Monatsblatter fur Augenheilkunde.
[7] W. C. Stewart,et al. Corneal Punctate Staining With Latanoprost, Bimatoprost, and Travoprost in Healthy Subjects , 2003, Journal of glaucoma.
[8] R. Sihota,et al. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[9] L. Roberts,et al. Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[10] J. Crider,et al. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. , 2003, Investigative ophthalmology & visual science.
[11] N. Sharif,et al. Bimatoprost (Lumigan®) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca2+ mobilization studies , 2003 .
[12] A. Fea,et al. Intraocular pressure and progression of visual field damage. , 2002, Acta ophthalmologica Scandinavica. Supplement.
[13] A. R. Gaudio,et al. Cystoid macular edema associated with ocular hypotensive lipids. , 2002, American journal of ophthalmology.
[14] N. Sharif,et al. Bimatoprost and its free acid are prostaglandin FP receptor agonists. , 2001, European journal of pharmacology.
[15] R. Brubaker. Mechanism of action of bimatoprost (Lumigan). , 2001, Survey of ophthalmology.
[16] J. Brandt,et al. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. , 2001, Survey of ophthalmology.
[17] R. Lai,et al. The pharmacology of bimatoprost (Lumigan). , 2001, Survey of ophthalmology.
[18] R. Brubaker,et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. , 2001, American journal of ophthalmology.
[19] S. Hayreh. Blood supply of the optic nerve head. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[20] S. Drance,et al. Pharmacology of Glaucoma , 1992 .
[21] T. Tokoro,et al. [Effects of timolol and carteolol on ocular pulsatile blood flow]. , 1992, Nippon Ganka Gakkai zasshi.
[22] D. Trew,et al. Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma. , 1991, The British journal of ophthalmology.
[23] M. Langham. The influence of timolol clonidine and aminoclonidine on ocular blood flow in the rabbit and human subjects , 1990 .
[24] A. Bill,et al. Control of retinal and choroidal blood flow , 1990, Eye.
[25] P. Schilder. Ocular blood flow changes with increased vascular resistance external and internal to the eye , 1989, Acta ophthalmologica. Supplement.
[26] R. Stodtmeister,et al. Effect of different antiglaucomatous drugs on ocular perfusion pressures. , 1988, Journal of ocular pharmacology.